Is Beaten-Down Dexcom Stock a Buy on the Dip?
29/7 11:54
Last week was a tough one for Dexcom (NASDAQ: DXCM) shareholders. The maker of continuous blood glucose monitors lowered its forward revenue outlook when it reported second-quarter results on Friday, July 26....